The University Of Kentucky Research Foundation

The University of Kentucky Research Foundation, doing business as Research Foundation, is a tax-exempt nonprofit research subsidiary of the University of Kentucky that executes federal research contracts and grants as a prime recipient across biomedical sciences, agricultural research, veterinary diagnostics, and engineering. The foundation competes in full-and-open federal procurements with no set-aside designations, operating primarily as a research institution serving the federal government's scientific and educational missions.

The Research Foundation's concrete capabilities center on biomedical and agricultural research execution, veterinary diagnostic services, and higher education program delivery. Recent award examples include a $2.175 million NIDA clinical trial evaluating non-abstinence treatment outcomes for methamphetamine use disorder (awarded September 2025); a $1.4 million Defense Health Agency project studying leukemia-initiating cell biology (awarded September 2026); a $8.0 million Army cooperative agreement for advanced materials and manufacturing research (awarded March 2026); a $614 thousand Federal Highway Administration research contract on pavement management data quality assurance (awarded October 2025, with Iowa State University as a named subcontractor); and a $750 thousand NIFA grant supporting undergraduate STEM education in animal science through the Stable to STEM program (awarded August 2026). The foundation also operates a significant veterinary services portfolio: a $352 thousand FDA food safety contract for Kentucky animal food inspection (awarded July 2026, ultimate completion July 2031) and a $43.2 thousand Veterans Affairs veterinary R&D call order under a five-year blanket purchase agreement ceiling of $350 thousand running through September 2027.

Customer concentration is heavily weighted to the National Institutes of Health. The National Cancer Institute, National Institute on Aging, National Institute on Drug Abuse, and other NIH institutes dominate the funding landscape by both award count and dollar value. The top five customer agencies (NSF, NIH, USDA NIFA, USDA APHIS, and NIH NIA) account for 34 percent of awards. By potential value, NIH National Cancer Institute awards represent $913.7 million combined across 176 awards—a concentration that reflects the foundation's deep research infrastructure and established relationships in oncology, Alzheimer's disease, aging, and translational medicine. Recent awards show engagement across HHS, NASA, Defense Health Agency, Department of Veterans Affairs, and USDA agencies, but the federal research grant ecosystem—not federal contracting—drives the majority of its activity.

The Research Foundation holds no major government-wide contract vehicles (GWACs or schedules) in its own name. Its contract work is primarily structured as direct awards from federal agencies (e.g., definitive contracts, delivery orders on established IDVs, and blanket purchase agreements with single agencies such as the VA and FDA). The SCI dataset shows minimal service-contract activity above the reporting threshold: $15.4 million in prime invoicing across FY2022–FY2024, with notable volatility ($12.3 million in FY2022, zero in FY2023, $3.1 million in FY2024). Across prime SCI records, the Research Foundation delivers services using minimal subcontractor engagement—the SCI sub-hours share is 0 percent, indicating it staffs most federal service contracts with its own personnel. FTE staffing on SCI-reportable work was 1.1 FTEs (FY2022), zero (FY2023), and 2.9 FTEs (FY2024).

The Research Foundation's portfolio reveals a research institution with heavy reliance on NIH grants and federal research support across life sciences, agriculture, and defense biomedical domains. As of the most recent activity, the foundation holds 4,726 total awards (prime and sub) with combined potential value of $1.11 billion, though cumulative dollars obligated ($5.41 billion) substantially exceed potential value due to multi-year grant continuation and task order execution. Award activity has grown from 259 in 2023 to 435 in 2024, with 313 awards in 2025 and slowing to 107 in 2026 (reflecting later data capture). The recompete cliff shows 389 awards reaching ultimate completion in the next twenty-four months with combined potential value of $38.2 million, creating near-term renewal exposure across NIH, USDA, and NSF programs. The foundation operates from Lexington, Kentucky, and serves as a critical extension of the University of Kentucky's land-grant research and outreach mission into federal biomedical and agricultural science portfolios.